Search research articles
Contact Us
Filters
Showing results (441-450 of 526) with videos related to
Page
of 53
Sort By:
Journal of Pharmacological Sciences
|
January 23, 2004
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene
Hirokazu Mizoguchi, Hsiang-En Wu, Minoru Narita, et al.
Expert Opinion on Pharmacotherapy
|
February 27, 2009
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
O Löwenstein, P Leyendecker, M Hopp, et al.
European Journal of Medicinal Chemistry
|
July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitor
D E Dar, M Thiruvazhi, P Abraham, et al.
Plos One
|
June 3, 2017
Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing
Kyung-Hwa Park, Kerryl E Greenwood-Quaintance, James R Uhl, et al.
Methods in Molecular Medicine
|
March 2, 2006
Molecular neurobiological methods in marijuana-cannabinoid research
George R Uhl, Hiroki Ishiguro, Emmanuel S Onaivi, et al.
Journal of Studies on Alcohol and Drugs
|
November 21, 2024
Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth
David W Sosnowski, Jill A Rabinowitz, Kenneth A Feder, et al.
Behavioural Pharmacology
|
September 29, 2025
Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice
Kentaro Matsuda, Nobue Kitanaka, Frank Scott Hall, et al.
Archives of General Psychiatry
|
September 1, 1992
Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers
S S Smith, B F O'Hara, A M Persico, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Page
of 53
Search research articles
Search
Showing results (441-450 of 526) with videos related to
Sort By:
Page
of 53
Journal of Pharmacological Sciences
|
January 23, 2004
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene
Hirokazu Mizoguchi, Hsiang-En Wu, Minoru Narita, et al.
Expert Opinion on Pharmacotherapy
|
February 27, 2009
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
O Löwenstein, P Leyendecker, M Hopp, et al.
European Journal of Medicinal Chemistry
|
July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitor
D E Dar, M Thiruvazhi, P Abraham, et al.
Plos One
|
June 3, 2017
Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing
Kyung-Hwa Park, Kerryl E Greenwood-Quaintance, James R Uhl, et al.
Methods in Molecular Medicine
|
March 2, 2006
Molecular neurobiological methods in marijuana-cannabinoid research
George R Uhl, Hiroki Ishiguro, Emmanuel S Onaivi, et al.
Journal of Studies on Alcohol and Drugs
|
November 21, 2024
Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth
David W Sosnowski, Jill A Rabinowitz, Kenneth A Feder, et al.
Behavioural Pharmacology
|
September 29, 2025
Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice
Kentaro Matsuda, Nobue Kitanaka, Frank Scott Hall, et al.
Archives of General Psychiatry
|
September 1, 1992
Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers
S S Smith, B F O'Hara, A M Persico, et al.
Psychopharmacology
|
March 23, 2007
Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice
Setsu Fukushima, Haowei Shen, Harumi Hata, et al.
Biochemical and Biophysical Research Communications
|
February 16, 2013
Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice
Arihisa Ohara, Yoshiyuki Kasahara, Hideko Yamamoto, et al.
Page
of 53